Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP553866.RARNISdu59Z7bsHfy3zczgrgmykaByae3BjJNuYo5uN_I130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553866.RARNISdu59Z7bsHfy3zczgrgmykaByae3BjJNuYo5uN_I130_provenance.
• NP553899.RAay0DPlMYRigRhye3hJdoSgrWpVaFM3Iw6vQzwPeDuyE130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553899.RAay0DPlMYRigRhye3hJdoSgrWpVaFM3Iw6vQzwPeDuyE130_provenance.
• NP802761.RAdlh-FSFJA4PrK8Vclb9DiNpGFFftAI-dUylmOb9mLng130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802761.RAdlh-FSFJA4PrK8Vclb9DiNpGFFftAI-dUylmOb9mLng130_provenance.
• NP945732.RAWDQCbUauhsPYzKmGjbpKxkZ8P3W6Kb30RJn1fzmc4hw130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945732.RAWDQCbUauhsPYzKmGjbpKxkZ8P3W6Kb30RJn1fzmc4hw130_provenance.
• NP802789.RAgTVT0wSDaw-SUaymkoNdCzpYuFJBC37aZkZraGgnfwg130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802789.RAgTVT0wSDaw-SUaymkoNdCzpYuFJBC37aZkZraGgnfwg130_provenance.
• NP803167.RArfc49R2WCGWavKqaD-cCYkcpnfz7noikiTX3_KHQfJM130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803167.RArfc49R2WCGWavKqaD-cCYkcpnfz7noikiTX3_KHQfJM130_provenance.
• NP945704.RAlwXSBU3O5ZF3iR127CZIgf0q2aSTMTQU_q_v_43wCrY130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945704.RAlwXSBU3O5ZF3iR127CZIgf0q2aSTMTQU_q_v_43wCrY130_provenance.
• NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1132969.RAsA-fSXo2oZz8dbR3hPa0Nx8tkNWDttnxE1r4VhHX4sQ130_provenance.
• NP1132970.RAnVSIHzTfudxZbiteXMtsuXQCC-GRSHhEPnX6tw1tdPs130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1132970.RAnVSIHzTfudxZbiteXMtsuXQCC-GRSHhEPnX6tw1tdPs130_provenance.
• NP554459.RA08yvs5xqnJe31sNo1UwgFPSsC4ehj9qMPuA51pJ72Cs130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554459.RA08yvs5xqnJe31sNo1UwgFPSsC4ehj9qMPuA51pJ72Cs130_provenance.
• NP946110.RAymZHnsedzhZN9_UT2HZQPkycRAx3X33_edtgZzpragI130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946110.RAymZHnsedzhZN9_UT2HZQPkycRAx3X33_edtgZzpragI130_provenance.
• NP1132971.RA0jIhFk2K_V21RziPx8LYOMw2LMoI-DGZnIWouPrjZEc130_assertion description "[The concept of using information from a patient's tumor to make therapeutic and treatment decisions has revolutionized the landscape for cancer care and research in general.Management of non-small-cell lung cancer, in particular, has seen several of these advances, with the understanding of activating mutations in EGFR, fusion genes involving ALK, rearrangements in ROS-1, and ongoing research in targeted therapies for K-RAS and MET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1132971.RA0jIhFk2K_V21RziPx8LYOMw2LMoI-DGZnIWouPrjZEc130_provenance.